Advertisement
Australia markets close in 4 hours 47 minutes
  • ALL ORDS

    8,029.20
    +26.40 (+0.33%)
     
  • ASX 200

    7,787.20
    +27.60 (+0.36%)
     
  • AUD/USD

    0.6626
    -0.0025 (-0.37%)
     
  • OIL

    81.99
    +0.25 (+0.31%)
     
  • GOLD

    2,330.50
    -6.10 (-0.26%)
     
  • Bitcoin AUD

    93,339.97
    +1,223.21 (+1.33%)
     
  • CMC Crypto 200

    1,281.27
    +15.13 (+1.20%)
     
  • AUD/EUR

    0.6196
    -0.0010 (-0.16%)
     
  • AUD/NZD

    1.0921
    -0.0005 (-0.05%)
     
  • NZX 50

    11,717.43
    -117.59 (-0.99%)
     
  • NASDAQ

    19,789.03
    +37.98 (+0.19%)
     
  • FTSE

    8,179.68
    -45.65 (-0.55%)
     
  • Dow Jones

    39,164.06
    +36.26 (+0.09%)
     
  • DAX

    18,210.55
    +55.31 (+0.30%)
     
  • Hang Seng

    17,716.47
    0.00 (0.00%)
     
  • NIKKEI 225

    39,646.89
    +305.35 (+0.78%)
     

Scientex Berhad Third Quarter 2024 Earnings: EPS: RM0.084 (vs RM0.071 in 3Q 2023)

Scientex Berhad (KLSE:SCIENTX) Third Quarter 2024 Results

Key Financial Results

  • Revenue: RM1.11b (up 11% from 3Q 2023).

  • Net income: RM130.5m (up 19% from 3Q 2023).

  • Profit margin: 12% (in line with 3Q 2023).

  • EPS: RM0.084 (up from RM0.071 in 3Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scientex Berhad Earnings Insights

Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Chemicals industry in Malaysia.

Performance of the Malaysian Chemicals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Scientex Berhad you should know about.

ADVERTISEMENT

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com